Shire Plc said that it has agreed with AbbVie Inc to end their proposed merger, and that a break fee of $1.635 billion is now payable to it. The Dublin, Ireland-based company said it was well positioned to continue as an independent business. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals